Neurogene (NGNE) Total Liabilities: 2018-2025
Historic Total Liabilities for Neurogene (NGNE) over the last 6 years, with Sep 2025 value amounting to $22.3 million.
- Neurogene's Total Liabilities fell 16.53% to $22.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.3 million, marking a year-over-year decrease of 16.53%. This contributed to the annual value of $25.4 million for FY2024, which is 30.63% down from last year.
- Per Neurogene's latest filing, its Total Liabilities stood at $22.3 million for Q3 2025, which was down 7.35% from $24.1 million recorded in Q2 2025.
- In the past 5 years, Neurogene's Total Liabilities ranged from a high of $36.5 million in Q4 2023 and a low of $14.4 million during Q3 2023.
- Its 3-year average for Total Liabilities is $23.1 million, with a median of $24.1 million in 2025.
- Examining YoY changes over the last 5 years, Neurogene's Total Liabilities showed a top increase of 86.09% in 2024 and a maximum decrease of 30.63% in 2024.
- Over the past 3 years, Neurogene's Total Liabilities (Quarterly) stood at $36.5 million in 2023, then slumped by 30.63% to $25.4 million in 2024, then declined by 16.53% to $22.3 million in 2025.
- Its Total Liabilities stands at $22.3 million for Q3 2025, versus $24.1 million for Q2 2025 and $23.5 million for Q1 2025.